Results 11 to 20 of about 235,727 (237)

Antiparasitic treatment with itraconazole and amiodarone in 2 dogs with severe, symptomatic Chagas cardiomyopathy

Journal of Veterinary Internal Medicine, 2022
Chagas cardiomyopathy, caused by the protozoal parasite Trypanosoma cruzi, is characterized by arrhythmias, myocardial damage, heart failure, and sudden death.
Elizabeth L. Malcolm, Ashley B. Saunders, Jordan P. Vitt, Bruno G. Boutet, Sarah A. Hamer   +4 more
doaj   +3 more sources

Biomakers in Chronic Chagas Cardiomyopathy. [PDF]

Microorganisms, 2022
The primary objective was to observe the relationship between serum levels of BNP, Ca-125, C-reactive protein and uric acid as prognostic and functional markers in patients with chronic Chagas cardiomyopathy (CCC). Circulating levels of cytokines: IL-1β, TNFα, IL-10, IL6, IL-8 and IL-12 were determined and investigated regarding their association with ...
Rodrigues AB, da Gama Torres HO, Nunes MDCP, de Assis Silva Gomes J, Rodrigues AB, Pinho LLN, Rocha MO, Botoni FA.   +7 more
europepmc   +5 more sources

Heart transplantation for Chagas cardiomyopathy

Revista Portuguesa de Cardiologia, 2017
Chagas disease is an endemic disease in Latin America that is increasingly found in non-endemic areas all over the world due to the flow of migrants from Central and South America.
Ana Rita Ramalho, David Prieto, Pedro Antunes, Fátima Franco, Manuel J. Antunes   +4 more
doaj   +7 more sources

Chagas Disease Cardiomyopathy: Immunopathology and Genetics [PDF]

Mediators of Inflammation, 2014
Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America and affects ca. 10 million people worldwide. About 30% of Chagas disease patients develop chronic Chagas disease cardiomyopathy (CCC), a particularly lethal ...
Edecio Cunha-Neto, Christophe Chevillard
doaj   +5 more sources

Scientometrics analysis of research activity and collaboration patterns in Chagas cardiomyopathy. [PDF]

PLoS Neglected Tropical Diseases, 2018
Chagas cardiomyopathy is a serious and common complication of Chagas disease.Through bibliometric and Social Network Analysis, we examined patterns of research on Chagas cardiomyopathy, identifying the main countries, authors, research clusters, and ...
Gregorio González-Alcaide, Alejandro Salinas, José M Ramos   +2 more
doaj   +5 more sources

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy

Revista da Sociedade Brasileira de Medicina Tropical, 2021
INTRODUCTION: The minute ventilation-carbon dioxide production relationship (VE/VCO2 slope) is among the main prognostic factors of Chagas cardiomyopathy whose determinants remain unknown. METHODS: Seventy-eight patients with Chagas cardiomyopathy were
Lucas Frois Fernandes Oliveira, Janaina Martins Andrade, Pedro Henrique Scheidt Figueiredo, Matheus Ribeiro Ávila, Whesley Tanor Silva, Marcus Vinicius Accetta Vianna, Renato Guilherme Trede Filho, Henrique Silveira Costa, Manoel Otávio Costa Rocha, Vanessa Pereira Lima   +9 more
doaj   +2 more sources

Association of left ventricular abnormalities with incident cerebrovascular events and sources of thromboembolism in patients with chronic Chagas cardiomyopathy

Journal of Cardiovascular Magnetic Resonance, 2022
Background Although Chagas cardiomyopathy is related to thromboembolic stroke, data on risk factors for cerebrovascular events in Chagas disease is limited.
Henrique Turin Moreira, Gustavo Jardim Volpe, Gustavo Marques Mesquita, Maria Fernanda Braggion-Santos, Antonio Pazin-Filho, José Antonio Marin-Neto, André Schmidt   +6 more
doaj   +2 more sources

Circulating microRNAs as biomarkers of Chagas cardiomyopathy [PDF]

Frontiers in Cardiovascular Medicine, 2023
BackgroundChagas cardiomyopathy (CHCM) is the most important clinical manifestation of Chagas disease. The analysis of cardiac miRNAs may contribute to predicting the progression to CHCM in Chagas indeterminate phase and/or to the differential diagnosis ...
Laura Antonietti, Laura Antonietti, Javier Mariani, Javier Mariani, María Jose Martínez, Manuela Santalla, Natalia Vensentini, Diego Alfredo Kyle, Maximiliano de Abreu, Maximiliano de Abreu, Carlos Tajer, Carlos Tajer, Ezequiel Lacunza, Paola Ferrero   +13 more
doaj   +2 more sources

Correlation of TcII discrete typing units with severe chronic Chagas cardiomyopathy in patients from various Brazilian geographic regions

PLoS Neglected Tropical Diseases, 2022
Background Chagas disease (ChD) is caused by Trypanosoma cruzi. The genetic structure of the species is divided into seven distinct genetic groups, TcI to TcVI, and Tcbat, which have shown differences in terms of geographic distribution, biological ...
Maykon Tavares de Oliveira, Carlos Alessandro Fuzo, Maria Cláudia Silva, Eduardo Antônio Donadi, João S. Silva, Henrique Turin Moreira, André Schmidt, José Antônio Marin‐Neto   +7 more
openalex   +3 more sources

Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi –Seropositive Individuals [PDF]

Circulation, 2021
Supplemental Digital Content is available in the text. Background: There are few contemporary cohorts of Trypanosoma cruzi–seropositive individuals, and the basic clinical epidemiology of Chagas disease is poorly understood.
Maria Carmo P. Nunes, Lewis F. Buss, Jose Luiz P. Silva, Larissa Natany A. Martins, Claudia Di Lorenzo Oliveira, Clareci Silva Cardoso, Bruno Oliveira de Figueiredo Brito, Ariela Mota Ferreira, Lea Campos Oliveira, Ana Luiza Bierrenbach, Fabio Fernandes, Michael P. Busch, Viviane Tiemi Hotta, Luiz Mario Baptista Martinelli, Maria Carolina F. Almeida Soeiro, Adriana Brentegani, Vera M.C. Salemi, Marcia M. Menezes, Antonio Luiz P. Ribeiro, Ester Cerdeira Sabino   +19 more
openalex   +2 more sources